Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Benzonatate

    Client Email Product

    Benzonatate

    APIs // Active Pharmaceutical Ingredients

    PRICE INFORMATION

    DOSSIERs // Finished Dosage Formulations

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Product SearchProduct Search
    API SUPPLIERS
    API Suppliers

    API Suppliers

    9
    US DMFs Filed

    US DMFs Filed

    7
    CEP/COS Certifications

    CEP/COS Certifications

    0

    JDMFs Filed

    JDMFs Filed

    0

    Other Certificates

    Other Certificates

    0

    Other Suppliers

    Other Suppliers

    5
    API REF. PRICE (USD / KG)
    109

    API Market Place

    6
    INTERMEDIATES

    0

    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    34
    Europe

    Europe

    0

    Canada

    Canada

    0

    Australia

    Australia

    0

    South Africa

    South Africa

    0

    Uploaded Dossiers

    Uploaded Dossiers

    6
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    3.00

    Annual Reports

    0

    FDF Market Place

    0

    EXCIPIENTS
    87
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    0

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    0

    News

    7
    REF STANDARD

    EDQM

    0

    USP

    1

    JP

    0

    Other Listed Suppliers

    1
    SERVICES
    1
    left grey arrow
    right gray arrow
    • CAPSULE;ORAL - 100MG
    • CAPSULE;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
    Full View ScreenFull Screen View
    Enforcement Report - Week of January 31, 2024
    Enforcement Report - Week of January 31, 2024

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-31-2024-59527.pdf

    FDA
    31 Jan 2024
    Share Share
    FDA warns of rise in reports of child poisonings linked to cough medicine
    FDA warns of rise in reports of child poisonings linked to cough medicine

    https://www.nbcnews.com/health/health-news/fda-warns-rise-reports-child-poisonings-linked-cough-medicine-rcna57065

    NBC NEWS
    15 Nov 2022
    Share Share
    Puracap Pharm's Generic Benzonatate Receives Approval in US
    Puracap Pharm's Generic Benzonatate Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206948

    FDA
    19 Dec 2018
    Share Share
    Aiping Pharm's Generic Benzonatate Receives Approval in US
    Aiping Pharm's Generic Benzonatate Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210562

    FDA
    13 Nov 2018
    Share Share
    Enforcement Report - Week of May 31, 2017
    Enforcement Report - Week of May 31, 2017

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-31-2017-1496224025.pdf

    FDA
    31 May 2017
    Share Share
    American Health Packaging, Ongoing Class II recall of Benzonatate Capsules, USP, 100 mg, 100 count (10X10), Rx only, Packaged and Distributed by: American Health Packaging Columbus, Ohio 43217 --- NDC 68084-214-01(carton) NDC 68084-214-11 (individual dose) because of Failed Tablet/Capsule Specifications; recall initiated by manufacturer due to reports of wet capsules
    American Health Packaging, Ongoing Class II recall of Benzonatate Capsules, USP, 100 mg, 100 count (10X10), Rx only, Packaged and Distributed by: American Health Packaging Columbus, Ohio 43217 --- NDC 68084-214-01(carton) NDC 68084-214-11 (individual dose) because of Failed Tablet/Capsule Specifications; recall initiated by manufacturer due to reports of wet capsules

    http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0430-2015&w=04082015&lang=eng

    FDA
    08 Apr 2015
    Share Share
    Zydus Pharmaceuticals USA Inc, Ongoing Class II recall of Benzonatate Capsules, USP, 100 mg, Rx only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India; Distributed by: Zydus Pharmaceuticals USA, In, Pennington, NJ USA 08534; 100-bottle capsules - NDC 68382-247-01 500-bottle capsules - NDC 68382-247-05 because of Failed Tablet/Capsule Specifications: Recall due to wet and/or leaking capsules.
    Zydus Pharmaceuticals USA Inc, Ongoing Class II recall of Benzonatate Capsules, USP, 100 mg, Rx only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India; Distributed by: Zydus Pharmaceuticals USA, In, Pennington, NJ USA 08534; 100-bottle capsules - NDC 68382-247-01 500-bottle capsules - NDC 68382-247-05 because of Failed Tablet/Capsule Specifications: Recall due to wet and/or leaking capsules.

    Http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0325-2015&w=12312014&lang=eng
    31 Dec 2014
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search